On June 5, 2023, ZYUS Life Sciences Inc. closed the transaction. The company issued 12,581,332 subscription receipts at an issue price of CAD 1.60 per subscription receipt for gross proceeds of CAD 20,130,131.20.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 CAD | -6.93% | -6.93% | +4.44% |
1st Jan change | Capi. | |
---|---|---|
+4.44% | 48.63M | |
+21.70% | 46.93B | |
+37.63% | 39.08B | |
-8.36% | 38.48B | |
+29.63% | 31.01B | |
-13.75% | 26.14B | |
+11.15% | 25.88B | |
+35.63% | 12.53B | |
-6.56% | 11.36B | |
-12.31% | 10.65B |
- Stock Market
- Equities
- ZYUS Stock
- News ZYUS Life Sciences Corporation
- ZYUS Life Sciences Inc. announced that it has received CAD 20.130131 million in funding from Phoenix Canada Oil Company Limited